drugset / Trial / NCT02656160
Effect of Dalfampridine (4-AP) on Genioglossus Muscle Activity in Healthy Adults
RandomizedCrossoverSingle-blindTreatment
Summary
In this protocol the investigators will test the effect of dalfampridine (a potassium channel blocker) on genioglossus muscle activity (EMG GG) during wakefulness and sleep in healthy control subjects.
Timeline
- Start
- 2016-01
- Primary completion
- 2016-05
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dalfampridine | Small molecule | 10 mg | — |